2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Advanced CRC: Is Recently FDA Approved Encorafenib + Cetuximab a New SoC for Previously Treated BRAF V600E-mutant mCRC? Can T-DXd Be an Option for HER2+ Disease?

190 views
July 14, 2020
Comments 0
Login to view comments. Click here to Login